Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin in Cutaneous T-cell Lymphoma
NCT00969085Phase 2Withdrawn
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2012
- Primary completion
- Nov 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
A Phase 2 trial of curcumin in mycosis fungoides (MF), Sézary syndrome (SS), sponsored by University of Texas MD Anderson Cancer Center. Planned start Nov 2012; status: withdrawn.
02
Drugs
curcumin
03
Conditions
mycosis fungoides (MF)Sézary syndrome (SS)
Beyond the preview
Go deeper on NCT00969085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00969085.